The New Science and Concepts That Underlie Current and Future Treatments for Myeloproliferative Neoplasms

Affiliations

• ¹ Tisch Cancer Institute, Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1079, New York, NY 10029, USA. Electronic address: ronald.hoffman@mssm.edu.
• ² Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program, Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Electronic address: leviner@mskcc.org.
• ³ Tisch Cancer Institute, Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1079, New York, NY 10029, USA. Electronic address: john.mascarenhas@mssm.edu.
• ⁴ Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Service, 530 East 74th Street, New York, NY 10021, USA. Electronic address: rampalr@mskcc.org.